A94B Respiratory core skills for HCAs & Assistant Practitioners
Course summary
This course improves knowledge of, and ability to support a multidisciplinary approach in the diagnosis of suspected airways conditions namely COPD and asthma. The course provides fundamental education on risk and symptom burden using validated assessment tools which support a multidisciplinary approach in the monitoring of COPD and asthma. Practical skills include the role and technique of peak flow measurements, an overview of inhaler devices including inhaler device assessment and checking inhaler device technique. The course provides information on the benefits of lung condition support organisations and services as well as relevant lifestyle information to support a proactive approach to lung health.
Who should attend?
Health Care Assistants
Health Care Support Workers
Important notes
The delegates will need to attend with a peak flow meter and as many placebo devices as they can.
These can be obtained from pharmaceutical reps.
Evaluations and certificate of attendance provided.
The course will run from 10:00am- 4:30pm
Cost
Course duration | Course CPD | In-house Course |
---|---|---|
1 day(s) | 7 hour(s) | POA |
In-house enquiry
Aims / objectives
At the end of the day the participant will be able to:
Describe the main symptoms of patients with asthma and COPD
Support a multidisciplinary approach in the diagnosis and monitoring of asthma and COPD.
Work towards capabilities in inhaler technique assessment and inhaler technique checks.
Signpost the patient and family to services and resources to support self-management and understanding of asthma and COPD
Course programme
Anatomy and physiology of the lungs
Introduction to asthma and COPD and respiratory conditions in the U.K
The role of peak flow in suspected and confirmed airways conditions
Inhaler devices
The impact of respiratory disease on the patient, their family and carer
Signpost the patient, their family and carer to relevant organisations to support living with and managing asthma and COPD.
Led by
TBA